The cost-effectiveness of one-time opportunistic screening for atrial fibrillation in different age cohorts of inhabitants in Denmark aged 65 years and above: a Markov modelled analysis

Aims The objective was to evaluate the cost-effectiveness of one-time opportunistic screening for atrial fibrillation (AF) in general practice in citizens aged >= 65 years in Denmark compared to a no-screening alternative following current Danish practice. Methods and results A decision tree and a Markov model were designed to simulate costs and quality-adjusted life years (QALYs) in a hypothetical cohort of citizens aged >= 65 years equivalent to the Danish population (1 M citizens) over the course of 19 years, using a healthcare and societal perspective. Share of detected AF patients following opportunistic screening was retrieved from a recent Danish screening study, whereas the risk stroke and bleedings in AF patients were based on population data from national registries and their associated costs was obtained from published national registry studies. The present study showed that one-time opportunistic screening for AF was more costly, but also more effective compared to a no-screening alternative. The analysis predicts that one-time opportunistic screening of all Danes aged >= 65 years potentially can identify an additional 10 300 AF patients and prevent 856 strokes in the period considered. The incremental cost of such a screening programme is euro56.4 M, with a total gain of 6000 QALYs, resulting in an incremental cost-effectiveness ratio of euro9400 per QALY gained. Conclusion Opportunistic screening in general practice in citizens aged >= 65 years in Denmark is cost-effective compared to a willingness-to-pay threshold of euro22 000. The study and its findings support a potential implementation of opportunistic screening for AF at the general practitioner level in Denmark.

Automated summary

The study concluded that one-time opportunistic screening for atrial fibrillation in citizens aged >= 65 years in Denmark is cost-effective compared to a willingness-to-pay threshold of euro22 000. The screening program has the potential to identify a significant number of AF patients and prevent strokes, with an incremental cost-effectiveness ratio of euro9400 per QALY gained. The findings support the implementation of opportunistic screening for AF at the general practitioner level in Denmark.